127 related articles for article (PubMed ID: 3193400)
1. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
Hietala J; Syvälahti E; Röyttä M
J Recept Res; 1988; 8(6):753-71. PubMed ID: 3193400
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
3. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
Urwyler S; Coward D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
Noisin EL; Thomas WE
Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
[TBL] [Abstract][Full Text] [Related]
5. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
6. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
7. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
Coccini T; Manzo L; Costa LG
Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
[TBL] [Abstract][Full Text] [Related]
8. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
Leslie CA; Bennett JP
Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
[TBL] [Abstract][Full Text] [Related]
9. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
10. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization and autoradiographic localization of dopamine receptors in the rat adrenal medulla.
Barili P; Zaccheo D; Amenta F
Eur J Pharmacol; 1996 Aug; 310(2-3):129-35. PubMed ID: 8884208
[TBL] [Abstract][Full Text] [Related]
12. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
Theodorou A; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
Hietala J; Syvälahti E; Röyttä M
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
[TBL] [Abstract][Full Text] [Related]
14. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
De Vries DJ; Beart PM
Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
[TBL] [Abstract][Full Text] [Related]
15. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
Gundlach AL; Largent BL; Snyder SH
Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
Weller ME; Rose S; Jenner P; Marsden CD
Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
[TBL] [Abstract][Full Text] [Related]
18. 3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.
Werle E; Lenz T; Strobel G; Weicker H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):28-34. PubMed ID: 2853303
[TBL] [Abstract][Full Text] [Related]
19. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
20. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
Gundlach AL; Krstich M; Beart PM
Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
